AstraZeneca asks FDA for emergency authorisation for new COVID-19 treatment

 

The drug maker is asking for emergency FDA authorization for its antibody treatment to help prevent COVID-19, which would help prevent disease for high-risk Americans with compromised immune systems.

Subscribe and get top news delivered to your Inbox everyday for FREE